Related Experiment Video
Updated: Jun 6, 2026

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
Published on: March 3, 2021
Unlocking the application potential of AlphaFold3-like approaches in virtual screening
Chao Shen1,2,3, Xujun Zhang2,4, Shukai Gu2,4
1Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang 310003 China shenchao513@zju.edu.cn tingjunhou@zju.edu.cn.
AlphaFold3 (AF3) shows strong potential for structure-based virtual screening (VS) using its internal confidence metrics for ranking compounds. While effective, performance challenges arise with complex datasets and limited training data, yet it often outperforms traditional docking methods.
Area of Science:
- Computational Biology
- Structural Biology
- Drug Discovery
Background:
- Protein-ligand complex structure prediction has been revolutionized by AlphaFold3 (AF3).
- The application of AF3-like models for structure-based virtual screening (VS) is an emerging area requiring systematic evaluation.
- Existing virtual screening methods often face limitations in accuracy and efficiency.
Purpose of the Study:
- To systematically assess the efficacy of AlphaFold3-like approaches for structure-based virtual screening.
- To compare the performance of AF3, Protenix, and Boltz-2 in virtual screening tasks.
- To identify the strengths and limitations of these advanced models in drug discovery pipelines.
Main Methods:
- Utilized AlphaFold3, Protenix, and Boltz-2 as representative models for virtual screening.
- Benchmarked performance on established datasets like DEKOIS2.0 and challenging custom datasets.
- Evaluated intrinsic confidence metrics and third-party scoring schemes for compound ranking.
- Assessed pose generation accuracy and conformational plausibility of predicted structures.
Main Results:
- AlphaFold3 demonstrated exceptional screening capability, primarily driven by its intrinsic confidence metrics.
- Both AF3 and Protenix served as robust pose generators, outperforming conventional docking tools in most scenarios.
- Performance declined in challenging cases, including chemically similar actives exclusion, novel GPCR datasets, and experimentally verified inactive compounds.
- Predicted poses generally adopted physically plausible conformations with minor structural artifacts.
Conclusions:
- AF3-like methods show significant promise for structure-based virtual screening in drug discovery.
- Intrinsic confidence metrics are key drivers of AF3's screening performance.
- Current limitations necessitate careful consideration for deployment in complex drug discovery scenarios.
- These models offer valuable insights and often surpass traditional docking accuracy, despite current constraints.
Related Concept Videos
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Drug Discovery: Overview

